2026 BPD Singapore Biopharmaceutical Bioprocess Development Summit Banner

Meeting Overview

Industry Speaker

Professional Visitors

Special Topic

Featured Event

Highlights

•Leverage craftsmanship and production capacity to unlock market potential in Asia-Pacific, particularly Southeast Asia.

Forum Schedule

View Full Forum Schedule

9/22

BPD Main Forum (Session 1)

09:00-09:10

Opening Remarks

09:10-09:40

Dialogue: A New Paradigm for the Globalization of China's Biopharmaceuticals: From Process Innovation to Ecosystem Collaboration

09:40-10:20

Panel: Ecosystem Collaboration in Global Supply Chain Restructuring: Resilience, Efficiency, and Cross-Border Integration

10:20-10:40

Networking Break

10:40-11:10

Keynote: From Global to Asia: Regionalization Strategy and Market Entry Pathways for Biopharmaceutical Companies

11:10-11:30

Keynote speech: Commercial Effectiveness for Biopharmaceuticals Entering ASEAN

Speaker: Shri Sarkar, Partner at L.E.K. Consulting

11:30-12:10

Panel: Southeast Asia Opportunities for Innovative Biologics: Aligning Demand, Localizing Technology, and Forming Commercial Partnerships

Panelist: Bo Ying, CEO of Abogen Biosciences

12:00-13:00

Lunch & Networking

XDC / BsAb-TCE

XDC (Session 1)

13:00-13:20

Keynote: Global Technology Trends and Current Competitive Landscape of XDC

13:20-13:40

Keynote: XDC Optimization Strategies for Linker and Payload Screening

13:40-14:00

Keynote Speech: Regulatory Considerations for Manufacturing and Controls of ADCs

Speaker: Audrey Jia, former FDA OBP CMC reviewer; Founder of Wonderfulland Regulatory Consulting

14:00-14:50

Panel Discussion: Latest Advances in Antibody Drug Research for Tumor Therapy

14:50-15:20

Tea break & Networking

BsAb-TCE (Session 1)

15:20-15:40

Keynote Speech: mRNA Reshapes the TCE Development Paradigm

Speaker: Bo Ying, CEO of Abogen Biosciences

15:40-16:00

Keynote Speech: Exploring the Clinical Application of TCE in Oncology

16:00-17:00

Panel Discussion: CMC Challenges in High-Expression Construct Development, Purification Processes, and Rigorous Aggregate Control

Regulations and Market Access in Southeast Asia

Regulation and Market Access in Southeast Asia (Session 2)

13:00-13:20

Keynote speech: Indonesia's Evolving Pharmaceutical Landscape: Regulatory Readiness and Market Access for Innovative Therapies

Speaker: Shanti Marlina Sibuea, BPOM, Acting Director of Production Control for Drugs, Narcotics, Psychotropics, and Precursors

13:20-13:40

Keynote Address: Advancing Cell and Gene Therapy and Clinical Research in Saudi Arabia: SFDA Regulations, Market Access, and Implementation Insights

Speaker: Abdulaziz AlSayyari, BiSynergic, Managing Partner

13:40-14:00

Keynote Speech: Market Access Strategy in Singapore from an MNC Perspective

Speaker: Jun Feng, J&J, APAC Market Access Director

14:00-14:20

Keynote Speech: Commercializing Gene Therapy Outside the US and Europe: Lessons from Thailand

Speaker: Veerachat Petpisit, Founder of Nouvogenes Therapeutics

14:20-14:35

Keynote Speech: Geopolitics, Supply Chains, and Market Access: Building a Resilient Biopharma Policy in India

Speaker: Gaurav Arora, Chief Commercial Officer, BioPharma Centrum

14:35-14:50

Dialogue: Regulatory pathways for biologic approval in India

Panelists: Gaurav Arora, Chief Commercial Officer, BioPharma Centrum; Vipul Doshi, Chief Quality and Compliance Officer and Global Head of Pharmacovigilance, Zydus Lifesciences

14:50-15:20

Tea break & Networking

15:20-15:35

Keynote Speech: Overview of Pharmaceutical Regulatory Policies in Malaysia

Cell Therapy

Cell Therapy (Session 2)

15:35-15:55

Keynote Speech: From Lab to Bedside: Navigating Unmet Needs in Late-Stage Solid Tumor Treatment with Cost-Effective CAR-T Therapy

Speaker: He Ting, CEO, IMUNOPHARM Technology

15:55-16:15

Keynote Address: Global Registration and Strategic Deployment of Innovative iPSC Cell Therapies

Speaker: Jing Fan, Hopstem therapeutics, Founder & CEO

16:15-16:35

Keynote: Engineering iPSCs for Efficient Industrial-Scale Cell Therapy Manufacturing

Speaker: Yen CHOO, NTU Lee Kong Chian School of Medicine, Associate Professor of Stem Cell Science and Regenerative Medicine

16:35-17:15

Panel Discussion: Global Development and Innovation Opportunities in Cell Therapy

Panelists: IASO; Frank Su, CEO of TCRCure; Xiaoming Peng, CEO of Lion TCR

9/23

AI for Pharmaceuticals

09:00-09:20

Keynote: AI Applications in Molecular Design and Target Discovery

Speaker: Lipeng Lai, XtalPi, Co-Founder & CIO

09:20-09:40

Keynote Speech: Harnessing Organoids and AI for Next-Generation Targeted Drug Discovery

Speaker: Haisheng Zhang, Signet Therapeutics, Founder & CEO

09:40-10:00

Keynote: Regulatory Compliance for AI in Pharmaceutical R&D

10:00-10:20

Keynote: AI-Driven Quality Control and Automated Data Analysis Platform

10:20-10:50

Networking

10:50-11:10

Keynote: Digital Twins and Intelligent Bioreactors

11:10-12:00

Panel Discussion: Adapting AI Algorithms to the Complexity and Variability of Biopharma CMC Workflows

Advanced Technology

13:00-13:20

Keynote Speech: Regulatory CMC Considerations for Biologics Technology Transfer

Speaker: Poh Jeff, Gilead, Regulatory Affairs CMC Lead

13:20-13:40

Keynote: Key Considerations and Challenges in Bispecific Antibody Purification

Speaker: Wei Zhang, BTI, Principal Scientist & Group Leader, Downstream Processing

13:40-14:00

Keynote Speech: The Role of Digitalization and Automation in Manufacturing Advanced Therapy Medicinal Products

Speaker: Vipul Doshi, Chief Quality and Compliance Officer, Global Head of Pharmacovigilance at Zydus Lifesciences

14:00-14:20

Keynote Speech: Challenges in Large-Scale Production and Technology Transfer

14:20-14:40

Keynote Speech: Advancements in Next-Generation Continuous Manufacturing Processes

14:40-15:00

Keynote: Innovations in Cell Culture Technologies – Serum-Free Media and High-Expression Cell Line Development

15:00-16:00

Panel Discussion: Global Regulations and Best Practices for Process Characterization and Validation

13:00-14:00

Panel Discussion: Common Challenges and Tailored Solutions for CMC Across Technology Platforms

14:00-14:20

Keynote Address: Comprehensive Strategies and Compliance Boundaries for Impurity Control and Residuals

14:20-14:40

Keynote speech: Implementing Soft Sensors in Fermentation Processes: A Practical Approach to Real-Time Monitoring and Process Optimization

Speaker: Junita Dwi Andhini, Bio Farma, QA Engineer

14:40-15:00

Keynote Speech: PEG-Free LNPs for Targeted mRNA Vaccine Delivery

Speaker: Yi Yan, BTI, A*STAR, Distinguished Principal Scientist

15:00-15:20

Keynote: Harnessing Cell Surface Glycans for Therapeutics

Speaker: Andre Choo, BTI, A*STAR, Deputy Executive Director

15:20-15:40

Keynote Address: Innovative R&D Directions for Exosomes

Southeast Asia Cooperation Opportunities

09:00-09:40

Panel Discussion: Southeast Asia Focus: How Innovative Biotechs Maximize R&D, Manufacturing, and Business Development Collaboration

Panelists: Ling Tong, BD VP/Head, Buchang BioPharma; Gang Qin, CEO, Gene Quantum; Vince Deng, Partner, Med-Fine Capital; Vijay P. Karwal, Managing Director, CBC Group; Lalit Baregama, CBO, Symbiotec Pharmalab

09:40-10:20

Panel Discussion: Regulation and Market Access for Biologics in Singapore and Southeast Asia

Panelists: Jin Shun, Managing Director at PharmaGend; Jun Feng, APAC Market Access Director at J&J; Daniel Lee, Head of Commercial at Menarini APAC

10:20-10:50

Networking

Small Nucleic Acids / Peptides / mRNA / Gene Therapy

10:50-11:10

Keynote Speech: Superior Extrahepatic Delivery via the PNP Platform and Clinical Applications

Speaker: H. Fai Poon, CEO of Sirnaomics

11:10-11:30

Keynote: Synthesis and GMP Manufacturing of Cyclic and Specially Modified Peptides

Speaker: Liu Dou, CEO of Shenzhen Oralead Pharma

11:30-11:50

Keynote: High-Yield Vector Production, Downstream Purification Processes, and Critical QC Points for Gene Therapy

Speaker: Claire Zhang, Gritgen, CTO

12:00-13:00

Lunch & Networking

13:00-14:00

Panel Discussion: Common Challenges and Tailored Solutions for CMC Across Technology Platforms

14:00-14:20

Keynote Address: Comprehensive Strategies and Compliance Boundaries for Impurity Control and Residuals

14:20-14:40

Keynote speech: Implementing Soft Sensors in Fermentation Processes: A Practical Approach to Real-Time Monitoring and Process Optimization

Speaker: Junita Dwi Andhini, Bio Farma, QA Engineer

14:40-15:00

Keynote Speech: PEG-Free LNPs for Targeted mRNA Vaccine Delivery

Speaker: Yi Yan, BTI, A*STAR, Distinguished Principal Scientist

15:00-15:20

Keynote: Harnessing Cell Surface Glycans for Therapeutics

Speaker: Andre Choo, BTI, A*STAR, Deputy Executive Director

15:20-15:40

Keynote Address: Innovative R&D Directions for Exosomes

Special Guest

Shanti Marlina

POM Agency

Director of Drug, Narcotic, Psychotropic, and Precursor Production Control (Acting)

H. Fai Poon

CEO

Sirnaomics

Abdulaziz AlSayyari

Managing Partner

BiSynergic

Zhang Wei

Group Leader, Principal Scientist

BTI, A*STAR

Jin Shun

Managing Director

PharmaGend Consulting Pte Ltd

Vipul Doshi

Chief Quality and Compliance Officer, Global Head of Pharmacovigilance

Zydus Lifesciences Limited

Ling Tong

BD VP/Head

Buchang BioPharma

Daniel Lee

Head of Commercial

Menarini APAC

Zhenbo Su

CEO

TCRCure Biological Technology

Lipeng Lai

Co-Founder & CIO

XtalPi

Ting He

CEO

IMUNOPHARM Technology

Jing Fan

Founder & CEO

Hopstem Therapeutics

Jun Feng

APAC Market Access Director

Johnson & Johnson

Claire Zhang

Chief Technology Officer

Gritgen

Haisheng Zhang

Founder & CEO

Signet Therapeutics

Andre Choo

Deputy Executive Director

BTI, A*STAR

Yi Yan YANG

Distinguished Principal Scientist

BTI, A*STAR

Gang Qin

CEO

Gene Quantum

Poh Jeff

Regulatory Affairs CMC Lead

Gilead Sciences

Junita Dwi Andhini

QA Engineering

PT Bio Farma

Liu Dou

CEO

Oralead Pharma

Veerachat Petpisit

CEO

Nouvogenes Therapeutics

Vince Deng

Partner

Med-Fine Capital

Shri Sarkar

Partner

L.E.K. Consulting

Yen CHOO

Associate Professor of Stem Cell Science and Regenerative Medicine

NTU Lee Kong Chian School of Medicine

Gaurav Arora

Chief Communications Officer

BioPharma Center

Audrey Jia

Founder of Wonderfulland Regulatory Consulting

ex-FDA OBP CMC Reviewer

Vijay P. Karwal

Managing Director

CBC Group

Bo Ying

CEO

Abogen Biosciences

Xiaoming PENG

CEO

Lion TCR